|
GABPA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.05649999859736E-09 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
8.997800E-01 |
| Stage1-vs-Stage3 |
7.642400E-03 |
| Stage1-vs-Stage4 |
1.58853999999709E-05 |
| Stage2-vs-Stage3 |
5.981600E-02 |
| Stage2-vs-Stage4 |
1.664590E-03 |
| Stage3-vs-Stage4 |
7.342200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.3640999996809E-07 |
| Normal-vs-Asian |
5.60218538225854E-12 |
| Caucasian-vs-AfricanAmerican |
5.694600E-01 |
| Caucasian-vs-Asian |
6.073200E-01 |
| AfricanAmerican-vs-Asian |
8.647400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
6.125800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62481139653892E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
2.621700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.530100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.676300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.963400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.625200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.720200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.505000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.10250000000278E-05 |
| Classical-VS-Follicular |
5.083400E-01 |
| Classical-VS-Other |
4.814400E-01 |
| Classical-VS-Normal |
3.172129225959E-12 |
| Tall-VS-Follicular |
8.37009999999916E-05 |
| Tall-VS-Other |
2.365400E-01 |
| Tall-VS-Normal |
1.11022302462516E-16 |
| Follicular-VS-Other |
4.058200E-01 |
| Follicular-VS-Normal |
1.75559566883976E-11 |
| Other-VS-Normal |
2.633800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62525548574877E-12 |
| N0-vs-N1 |
5.810100E-02 |
|
|
